Hyperlipidemia Prescription Drugs
Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 - 2019
Hyperlipidemia
refers to abnormal elevation of lipids and/or lipoprotein levels. Risk factors
associated with such condition include stroke, peripheral vascular disease, atherosclerosis,
diabetes, obesity, hypertension and other cardiovascular diseases. Drugs which
are used to treat hyperlipidemia act by either accelerating the elimination of
lipoproteins from the body or decrease production of lipoproteins. These medications
not only lower the unwanted cholesterol levels but also prove to be vital for
lowering the risk of heart attacks or strokes.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/hyperlipidemia-prescription-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The
global hyperlipidemic prescription drugs market is categorized based on drug
classes namely:
- HMG COA reductase inhibitors
- Fibric acid derivatives
- Nicotinic acid
- Bile acid sequestrating agents
- Cholesterol absorption inhibitors
- Combination drug therapy
North
America currently dominates the global hyperlipidemia prescription drugs market
and is followed by Europe due to high prevalence of diseases associated with
elevated levels of lipoproteins and the growing baby boomer population.
Emerging economies of Asia-Pacific, Latin America and Middle East are also
expected to undergo rapid market growth for hyperlipidemic drugs.
One
of the major factors driving the global hyperlipidemic prescription drugs
market is increasing susceptibility to heart diseases associated with aging
population. Other factors such as patent expiration and the consequent
genericization in the market, availability of funding and undertaking of health
awareness programs by healthcare centers, high incidence rates of
cardiovascular diseases and rising awareness among people for reducing the
harmful cholesterol levels to control heart diseases. A large number of
hyperlipidemia drugs are in phase III of clinical trials for their assessment
in providing clinical benefits and long-term safety records.
Some
of the key players contributing to hyperlipidemia prescription drugs market
include Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Pharmaceuticals
Limited, Isis Pharmaceuticals, Inc., Merck & Co., Inc., Dr. Reddy's
Laboratories Limited, Immuron Limited, Esperion Therapeutics, Inc., Pfizer,
Inc. and Formac Pharmaceuticals N.V.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This
report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
About
Us
Marketresearchreports.biz
is the most comprehensive collection of market research reports.
Marketresearchreports.biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
With a team of
experienced consultants we are committed to serve our clients in a way which
increase their efficiency, reduce costs and saves time. Our professional search
engine helps you in finding the best and latest market research report with
just one click of the mouse. Our database represents the most updates and
latest market research report collections form all the leading market research
publishers across the globe
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment